Memphasys Limited (MEM.AX)

AUD 0.01

(-14.29%)

Operating Expenses Summary of Memphasys Limited

  • Memphasys Limited's latest annual operating expenses in 2024 was 3.67 Million AUD , up 30.95% from previous year.
  • Memphasys Limited's latest quarterly operating expenses in 2024 FY was 3.61 Million AUD , up 28.64% from previous quarter.
  • Memphasys Limited reported a annual operating expenses of 2.8 Million AUD in annual operating expenses 2023, up 57.42% from previous year.
  • Memphasys Limited reported a annual operating expenses of 1.78 Million AUD in annual operating expenses 2022, up 24.43% from previous year.
  • Memphasys Limited reported a quarterly operating expenses of 3.61 Million AUD for 2024 FY, up 28.64% from previous quarter.
  • Memphasys Limited reported a quarterly operating expenses of 2.15 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Memphasys Limited (2024 - 2008)

Historical Annual Operating Expenses of Memphasys Limited (2024 - 2008)

Year Operating Expenses Operating Expenses Growth
2024 3.67 Million AUD 30.95%
2023 2.8 Million AUD 57.42%
2022 1.78 Million AUD 24.43%
2021 1.43 Million AUD 34.59%
2020 1.06 Million AUD -0.88%
2019 1.07 Million AUD -6.28%
2018 1.14 Million AUD -45.09%
2017 2.08 Million AUD 9.07%
2016 1.91 Million AUD 8.63%
2015 1.76 Million AUD 17.69%
2014 1.49 Million AUD -47.94%
2013 2.87 Million AUD -15.99%
2012 3.42 Million AUD -23.94%
2011 4.5 Million AUD 329.26%
2010 1.04 Million AUD -48.58%
2009 2.03 Million AUD -62.67%
2008 5.46 Million AUD 0.0%

Peer Operating Expenses Comparison of Memphasys Limited

Name Operating Expenses Operating Expenses Difference
AdAlta Limited 6.76 Million AUD 45.662%
Biome Australia Limited 7.91 Million AUD 53.504%
Radiopharm Theranostics Limited 299.22 Thousand AUD -1129.291%
Biotron Limited 5.11 Million AUD 28.026%
Acrux Limited 8.55 Million AUD 56.978%
Alterity Therapeutics Limited 23.4 Million AUD 84.285%
Botanix Pharmaceuticals Limited 601.82 Thousand AUD -511.21%
BTC Health Limited -1.03 Million AUD 454.056%
Chimeric Therapeutics Limited 19.76 Million AUD 81.392%
CSL Limited 7.56 Billion AUD 99.951%
Clarity Pharmaceuticals Ltd 56.3 Million AUD 93.467%
Clinuvel Pharmaceuticals Limited 31.29 Million AUD 88.247%
Immutep Limited 42.87 Million AUD 91.421%
Neuren Pharmaceuticals Limited 32.69 Million AUD 88.75%
Noxopharm Limited 7 Million AUD 47.453%
Prescient Therapeutics Limited 10.89 Million AUD 66.25%
Race Oncology Limited 14.77 Million AUD 75.096%
Starpharma Holdings Limited 22.81 Million AUD 83.878%
Tissue Repair Ltd 6.66 Million AUD 44.825%
EZZ Life Science Holdings Limited 39.57 Million AUD 90.705%
Anatara Lifesciences Ltd 710.21 Thousand AUD -417.924%
Bio-Gene Technology Limited 2.76 Million AUD -33.226%
Zelira Therapeutics Limited 5.94 Million AUD 38.163%
Patrys Limited 4.93 Million AUD 25.438%
Orthocell Limited 15.36 Million AUD 76.067%
Imugene Limited 135.09 Million AUD 97.277%
PYC Therapeutics Limited 60.91 Million AUD 93.962%
Proteomics International Laboratories Limited 892.14 Thousand AUD -312.309%
Cynata Therapeutics Limited 11.12 Million AUD 66.932%
Arovella Therapeutics Limited 10.78 Million AUD 65.894%
Nanollose Limited 12.5 Thousand AUD -29324.702%
Invex Therapeutics Ltd 3.34 Million AUD -9.938%
NeuroScientific Biopharmaceuticals Limited 1.96 Million AUD -87.174%
Amplia Therapeutics Limited 8.43 Million AUD 56.395%
Island Pharmaceuticals Limited 4.12 Million AUD 10.835%
Nyrada Inc. 4.55 Million AUD 19.248%
Telix Pharmaceuticals Limited 269.26 Million AUD 98.634%
Dimerix Limited 25.64 Million AUD 85.656%
PharmAust Limited 6.65 Million AUD 44.744%
Hexima Limited 1 Million AUD -264.648%
AnteoTech Limited 12.18 Million AUD 69.817%
Paradigm Biopharmaceuticals Limited 65.1 Million AUD 94.35%
Recce Pharmaceuticals Ltd 21.68 Million AUD 83.037%
Avecho Biotechnology Limited 4.54 Million AUD 19.075%
Actinogen Medical Limited 22.77 Million AUD 83.846%
Immuron Limited 9.13 Million AUD 59.746%
Argenica Therapeutics Limited 8.26 Million AUD 55.517%